Rojas-Rivera, JorgeDivision of Nephrology and Hypertension, Hospital Universitario Fundación Jiménez Díaz, IIS-Fundación Jiménez Díaz, and Autonomous University of Madrid, Madrid, SpainFervenza, Fernando C.Division of Nephrology and Hypertension, Mayo Clinic, Rochester, USAOrtiz, Alberto...
This meta-analysis assesses if women were underenrolled in contemporary randomized clinical trials of acute stroke therapies published in 9 major
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 被引量: 1发表: 2008年 Recent Advances in Chinese Medicine for Contrast-Induced Nephropathy Definition of ContrastInduced Nephropathy Contrast-induced nephropathy(CIN)...
Recent Trials in Hypertension: Compelling Science or Commercial Speech? With rare exceptions, hypertension is an asymptomatic risk factor for cardiovascular events such as myocardial infarction, stroke, and heart failure. In co... BM Psaty,NS Weiss,CD Furberg - 《Jama the Journal of the American...
More clinical trials are encouraged especially for peptides sourced from marine organisms, and seeds of soybean and lupin whose multifunctional properties in relation to hypertension have been well characterized. Finally, the current knowledge on structural-activity relationship of peptides in relation to...
Gheissari Alaleh Journal of Nephrology and Renal Disorders In the treatment of idiopathic nephrotic syndrome (INS) rituximab (RTX) as a chimeric CD20 blocker has been widely used. However, its efficacy in steroid-resistant nephrotic syndrome (SRNS) is debated...Physiochemical...
Prostate cancer (PCa) is the second largest male tumor in the world and one of the most common malignant tumors in the urinary system. In recent years, the
(EMA), with more treatments likely to follow. The global nephrology community’s concerted effort in recruiting patients from every continent for IgAN trials has been instrumental in this progress, with Europe playing a particularly crucial role. As Barratt aptly concluded...
The second-generation recombinant HDL, CSL-112, shows promising prospects and does not induce hepatotoxicity [180]. Phase I clinical trials indicated that CSL-112 significantly increased pre-β HDL levels (by 36-fold) and cholesterol efflux (by 270%), without causing liver damage [180,181]. ...
Pediatric NephrologyMorimoto, KeitaDivision of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, JapanYamanaka, ShuichiroKidney Applied Regenerative Medicine, Project Research Units, The Jikei University School of Medicine, Tokyo, JapanYokoo, Takashi...